Navigation Links
When Bystanders Become Lifesavers - Launch of Philips SaveLives.net
Date:6/7/2012

AMSTERDAM, The Netherlands, June 7, 2012 /PRNewswire/ --

Every minute-and-a-half in the U.S., and every 45 seconds in Europe, a person dies as a result of a sudden cardiac arrest[1,2]- if you witnessed a cardiac arrest, what would you do?

Royal Philips Electronics (NYSE: PHG, AEX: PHI) is today launching the Save Lives website (http://www.SaveLives.net), an online campaign to inform people across the world about sudden cardiac arrest and to empower them to act.

To view the Multimedia News Release, please click:

http://multivu.prnewswire.com/mnr/prne/philipshealthcare/53834/

Using award winning design to provide user-friendly information on key aspects of the condition, http://www.SaveLives.net aims to educate people on the importance of acting quickly when someone suffers from a sudden cardiac arrest. It includes advice on the use of automated external defibrillators (AED), which are simple to use, available in an increasing number of public places and when used correctly with cardiopulmonary resuscitation (CPR), significantly increase the chances of saving a life.

It is estimated that globally, approximately seven million people die of sudden cardiac arrest every year,[3] including an estimated 325,000 deaths in the U.S. and 700,000 across Europe.[1,2]

"Through SaveLives.net, Philips is looking to inspire and empower the general public to take action in cases of sudden cardiac arrest," commented Anthony Jones, Head of Marketing, Patient Care and Clinical Informatics, Philips Healthcare. "For the majority of people who suffer a cardiac arrest, a member of the public will be the first person onsite and able to provide treatment. SaveLives.net aims to ensure the action they take is the right action, and that they're ultimately able to help save lives."

A sudden cardiac arrest leaves the heart unable to beat regularly and for every minute before a victim is defibrillated, the chances of survival are reduced by between seven and 10 percent.[4] It is only by resetting the heart's rhythm with an electric current, delivered by a defibrillator, that a normal heart rhythm can be regained.

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs approximately 122,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.6 billion in 2011, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at http://www.philips.com/newscenter.

Background information on Philips Saves Lives website:

  • SaveLives.net uses real life survivor stories alongside a floating navigation system and an interactive walkthrough on defibrillation and CPR (cardiopulmonary resuscitation) to provide users with a unique learning experience and level of interaction
  • The Philips Save Lives website (http://www.SaveLives.net) is available in 13 countries/regions across the globe: Australia, England, France, Germany, India, Italy, Japan, New Zealand, Poland, Spain, Sweden, Taiwan and the U.S.

For media inquiries, please contact:
Sabine van Deursen
Philips Healthcare Communications
Tel: +31-40-2785-093
Email: sabine.van.deursen@philips.com

Steve Klink
Philips Corporate Communications
Tel: +31-6-1088-8824
E-mail: steve.klink@philips.com

References

  1. Heart Rhythm Foundation website - http://www.heartrhythmfoundation.org/facts/scd.asp (accessed May 2012)
  2. Koster et al. European Resuscitation Council Guidelines for Resuscitation 2010. Section 2. Adult basic life support and use of automated external defibrillators. Resuscitation 2010;81: 1277-1292
  3. Mehra R. 'Global public health problem of sudden cardiac death.' Journal of Electrocardiology 2007; 40 (6 Suppl):S118-22
  4. Callens D.J. New England Journal of Medicine 2004; 351:632

 


Video: http://multivu.prnewswire.com/mnr/prne/philipshealthcare/53834/



'/>"/>
SOURCE Royal Philips Electronics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
3. Mylan Launches Generic Version of Zyprexa® Tablets
4. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
5. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
6. American Academy of Family Physicians Foundation Launches Cities for Life
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched
9. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
10. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
11. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency ... Series, Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, ... University of Arizona College of Medicine. He also serves as Medical Director for the ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):